Olanrewaju Ayodeji Durojaye

9PUBLICATIONS
6CO-AUTHORS
Predictive and prognostic markersMicrofluidics and nanofluidicsComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Oral and maxillofacial surgeryMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 22, 2025
CCL18 and EGF May Serve as Potential Prognostic Biomarkers and Therapeutic Targets for Human Breast Cancer.

Sm Faysal Bellah, Fatema Akter Sonia, Md Razowanul Ferdous

|Apr 16, 2024
An in silico LLPS perturbation approach in the design of a novel SARS-CoV-2 spike receptor-binding domain inhibitor.

Olanrewaju Ayodeji Durojaye, Divine Mensah Sedzro, Talifhani Mushiana

|Apr 16, 2024
Potential therapeutic target identification in the novel 2019 coronavirus: insight from homology modeling and blind docking study.

Olanrewaju Ayodeji Durojaye, Talifhani Mushiana, Henrietta Onyinye Uzoeto

|Jul 31, 2023
Oral cavity infection by the SARS-CoV-2: emphasizing the essence of masking and peptide therapeutics.

Glory Omini Ibiang, Joseph Malachi, Mercy Omini Ibiang

|Jun 24, 2022
A New Variant of Mutational and Polymorphic Signatures in the ERG11 Gene of Fluconazole-Resistant Candida albicans.

Arome Solomon Odiba, Olanrewaju Ayodeji Durojaye, Ifeoma Maureen Ezeonu

|May 23, 2022
Identification of a Potential mRNA-based Vaccine Candidate against the SARS-CoV-2 Spike Glycoprotein: A Reverse Vaccinology Approach.

Olanrewaju Ayodeji Durojaye, Divine Mensah Sedzro, Mukhtar Oluwaseun Idris

Pageof 2